Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "accounting"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
language:"English"
Showing
21
-
36
of
36
Search:
'"accounting"'
,
query time: 0.04s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
21
Use of surgical masks in the operating room : a review of the clinical effectiveness and guidelines
Published 2013
Canadian Agency for Drugs and Technologies in Health
“
... infections (SSIs). SSIs
account
for a significant fraction of health care associated infections, however...
”
Read Now
22
Antibacterial sutures for wound closure after surgery : a review of clinical and cost-effectiveness and guidelines for use
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
...Surgical site infections (SSIs)
account
for approximately 20% of all compromised wounds...
”
Read Now
23
Axicabtagene ciloleucel for large B-cell lymphoma: Health technology assessment introduction and clinical review protocol
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
..., NHL
accounts
for 83% of all cases of lymphomas. In this context, axicabtagene ciloleucel is a chimeric...
”
Read Now
24
Use of surgical masks in the operating room : a review of the clinical effectiveness and guidelines
Published 2013
Canadian Agency for Drugs and Technologies in Health
“
... infections (SSIs). SSIs
account
for a significant fraction of health care associated infections, however...
”
Read Now
25
Antibacterial sutures for wound closure after surgery : a review of clinical and cost-effectiveness and guidelines for use
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
...Surgical site infections (SSIs)
account
for approximately 20% of all compromised wounds...
”
Read Now
26
Treatments for patients with genotype 1 chronic hepatitis C : a review of evidence-based guidelines
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
... infections
account
for most HCV infections in Canadians (55% to 65%). For these patients, standard therapy...
”
Read Now
27
Treatments for patients with genotype 1 chronic hepatitis C : a review of evidence-based guidelines
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
... infections
account
for most HCV infections in Canadians (55% to 65%). For these patients, standard therapy...
”
Read Now
28
Interferon-free regimens for genotype 1 chronic hepatitis C : a review of the clinical evidence and cost-effectiveness
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
.... There are six major HCV genotypes, and genotype 1
accounts
for approximately 60% of HCV infections in Canadians...
”
Read Now
29
Interferon-free regimens for genotype 1 chronic hepatitis C : a review of the clinical evidence and cost-effectiveness
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
.... There are six major HCV genotypes, and genotype 1
accounts
for approximately 60% of HCV infections in Canadians...
”
Read Now
30
Low-dose computed tomography for lung cancer screening : a review of the clinical effectiveness, diagnostic accuracy, cost-effectiveness, and guidelines
Published 2015
Canadian Agency for Drugs and Technologies in Health
Read Now
31
Pharmacoeconomic report: Eculizumab (Soliris) : Alexion Pharma Canada Corporation : indication : adult patients with generalized myasthenia gravis
Published 2020
Canadian Agency for Drugs and Technologies in Health
Read Now
32
Low-dose computed tomography for lung cancer screening : a review of the clinical effectiveness, diagnostic accuracy, cost-effectiveness, and guidelines
Published 2015
Canadian Agency for Drugs and Technologies in Health
Read Now
33
Obesity management interventions delivered in primary care for patients with osteoarthritis : a review of the clinical effectiveness
Published 2014
Canadian Agency for Drugs and Technologies in Health
Read Now
34
Obesity management interventions delivered in primary care for patients with osteoarthritis : a review of the clinical effectiveness
Published 2014
Canadian Agency for Drugs and Technologies in Health
Read Now
35
Pharmacoeconomic review report: Onabotulinumtoxin A (Botox) (Allergan inc.) : indication: for the prophylaxis of headaches in adults with chronic migraine (plus/minus 15 days per m...
Published 2019
CADTH
Read Now
36
Pharmacoeconomic review report: Onabotulinumtoxin A (Botox) (Allergan inc.) : indication: for the prophylaxis of headaches in adults with chronic migraine (plus/minus 15 days per m...
Published 2019
CADTH
1
2
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Clear Filter
Language: English
Year of Publication
From:
To:
Classification
610 - Medicine & health
20
330 - Economics
8
700 - The arts; fine & decorative arts
6
140 - Specific philosophical schools
3
576 - Genetics & evolution
2
600 - Technology
2
Language
English
Collection
National Center for Biotechnology Information
36
Author
Canadian Agency for Drugs and Technologies in Health
Severn, Melissa
2
Tran, Khai
2
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?page=2&filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&filter%5B%5D=language%3A%22English%22&lookfor=%22accounting%22&type=AllFields
Send by Email
×
Loading...